Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Operating Margin: 2010-2025

Historic Operating Margin for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to 61.84%.

  • Ironwood Pharmaceuticals' Operating Margin rose 3385.00% to 61.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 36.34%, marking a year-over-year increase of 1012.00%. This contributed to the annual value of 26.50% for FY2024, which is 24004.00% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Operating Margin stood at 61.84% for Q3 2025, which was up 16.31% from 53.17% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Operating Margin high stood at 63.77% for Q4 2022, and its period low was -1,008.68% during Q2 2023.
  • Moreover, its 3-year median value for Operating Margin was 31.98% (2023), whereas its average is -66.87%.
  • In the last 5 years, Ironwood Pharmaceuticals' Operating Margin plummeted by 106,592bps in 2023 and then spiked by 103,514bps in 2024.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Operating Margin stood at 48.32% in 2021, then surged by 1,546bps to 63.77% in 2022, then tumbled by 3,180bps to 31.98% in 2023, then spiked by 280bps to 34.78% in 2024, then soared by 3,385bps to 61.84% in 2025.
  • Its last three reported values are 61.84% in Q3 2025, 53.17% for Q2 2025, and -70.75% during Q1 2025.